Skip to main content
$42.89 $1.35 (3.3%)

04:00 PM EDT on 10/21/21

Intra-Cellular Therapies Inc. (NASDAQ:ITCI)

CAPS Rating: 3 out of 5

Current Price $42.89 Mkt Cap $3.4B
Open $41.77 P/E Ratio 0.00
Prev. Close $42.89 Div. (Yield) $0.00 (0.0%)
Daily Range $40.55 - $43.08 Volume 340,578
52-Wk Range $22.92 - $44.80 Avg. Daily Vol. 395,109

Caps

How do you think NASDAQ:ITCI will perform against the market?

Add Stock to CAPS Watchlist

All Players

40 Outperform
6 Underperform
 

All-Star Players

9 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ITCI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

odocoileus (58.66)
Submitted February 03, 2020

Was I lucky green-thumbing ITCI just before FDA approval? Well now that it's over I can pretty much say whatever I want. So, no, it was just savvy investing. I do better predicting FDA decisions than post approval sales. Seems regardless of market… More

Hendrickson71 (< 20)
Submitted January 06, 2016

Come on sugar factory, come down to earth already, Let's see some $40s this week,

NASDAQ:ITCI VS S&P 500 (SPY)

NASDAQ:ITCI Summary

Fools bullish on NASDAQ:ITCI are also bullish on:

Fools bearish on NASDAQ:ITCI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ITCI.

Recs

1
Member Avatar odocoileus (58.66) Submitted: 2/2/2020 7:00:11 PM : Outperform Start Price: $12.32 NASDAQ:ITCI Score: +203.60

Was I lucky green-thumbing ITCI just before FDA approval? Well now that it's over I can pretty much say whatever I want. So, no, it was just savvy investing. I do better predicting FDA decisions than post approval sales. Seems regardless of market size or marketing muscle, it's a crapshoot for me whether the drug will take off. So here we are. ITCI has a new class of drug in a huge indication. I'm hanging on expecting big things. Tell me what I'm missing.

Recs

0
Member Avatar emtking (51.21) Submitted: 12/13/2019 1:05:50 PM : Outperform Start Price: $12.60 NASDAQ:ITCI Score: +197.50

New drug for bipolar disorder looks as close to a sure thing as there can be going into an FDA decision date of December 278th or sooner, 2019.

Recs

0
Member Avatar LifeScientist (40.71) Submitted: 2/17/2016 2:37:17 PM : Outperform Start Price: $30.57 NASDAQ:ITCI Score: -94.59

watch 27 is an entry

Leaderboard

Find the members with the highest scoring picks in ITCI.

Score Leader

baselineace

baselineace (23.98) Score: +371.97

Sometimes you just get lucky?

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
odocoileus 58.66 12/11/2019 Outperform 5Y $12.32 +248.13% +44.53% +203.60 1 Comment
emtking 51.21 12/13/2019 Outperform 5Y $12.60 +240.40% +42.90% +197.50 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. km00nster 80.89 9/21/2015 Underperform 5Y $50.63 -15.29% +131.49% +146.77 1 Comment
Hendrickson71 < 20 1/7/2016 Underperform 3W $48.05 -10.74% +132.27% +143.01 1 Comment
stockgripes 99.05 9/16/2015 Underperform 5Y $45.15 -5.01% +127.17% +132.18 1 Comment
derbydog85 57.44 12/23/2016 Outperform 5Y $15.62 +174.58% +101.21% +73.37 0 Comment
Dananator 35.86 8/7/2020 Outperform 5Y $20.97 +104.58% +35.80% +68.78 0 Comment
joe508mama 29.94 9/30/2016 Outperform 5Y $15.41 +178.33% +110.38% +67.94 0 Comment
warrenout 30.12 9/30/2016 Outperform 3M $15.41 +178.33% +110.38% +67.94 0 Comment
jmdor2222 74.24 9/29/2016 Outperform 5Y $15.49 +176.89% +110.51% +66.38 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ITCI.